首页> 外文期刊>Natural product communications >Structural Analogues of Lanosterol from Marine Organisms of the Class Asteroidea as Potential Inhibitors of Human and Candida albicans Lanosterol 14 alpha-demethylases
【24h】

Structural Analogues of Lanosterol from Marine Organisms of the Class Asteroidea as Potential Inhibitors of Human and Candida albicans Lanosterol 14 alpha-demethylases

机译:从班级的海洋生物体植物体的结构性类似物,作为人和念珠菌含白葡萄球菌14α-脱甲基酶的潜在抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Lanosterol 14 alpha-demethylases (hemoproteins of the cytochrome P450(51) family) are involved in biosynthesis of different membrane sterols, including animal cholesterol, fungal ergosterol and C24-modified plant and protozoa sterols. In this study we have investigated 10 structural analogs of lanosterol isolated from echinoderms belonging to the class Asteroidea as potential ligands (competitive inhibitors) of human and Candida albicans cytochromes P450(51). The study was performed using the surface plasmon resonance method, spectrophotometric titration and enzyme assay. Among the compounds tested we found several selective ligands for human and Candida albicans cytochromes. Between selective ligands of the human lanosterol 14 alpha-demethylase we found two novel inhibitors of this enzyme: henricioside H-1 and levisculoside G from Henricia derjugini. With due consideration of obtained data, we conclude that marine organisms from the class Asteroidea can be a valuable source of new lead compounds for creation of selective inhibitors of cytochromes P450(51) family with less side effects due to their selective action on these enzymes in different types of organisms.
机译:Lanterol 14α-脱甲基酶(细胞色素P450(51)家族的血蛋白)涉及不同膜甾醇的生物合成,包括动物胆固醇,真菌Ergosterol和C24改性植物和原生动物甾醇。在这项研究中,我们研究了从属于Asteroidea类的棘手症中分离的Lanosterol醇的10种结构类似物,作为人和念珠菌常见的人和念珠菌的潜在配体(竞争性抑制剂)细胞学P450(51)。使用表面等离子体共振方法,分光光度滴定和酶测定进行该研究。在测试的化合物中,我们发现了几种用于人和念珠菌的选择性配体。人Lanterol醇的选择性配体在14α-脱甲基酶的选择性配体中,我们发现了来自Henricia derjugini的Henricies H-1和Lemisculoside G的两种新抑制剂。随着对获得的数据的适当考虑,我们得出结论,来自Asteroidea类的海洋生物可以是新的铅化合物的宝贵来源,用于产生细胞色素P450(51)系列的选择性抑制剂,由于它们对这些酶的选择性作用而较少的副作用不同类型的生物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号